Viewing Study NCT05774951

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 11:45 PM

Ignite Modification Date: 2025-12-25 @ 9:38 PM

Study NCT ID: NCT05774951

Status: RECRUITING

Last Update Posted: 2025-12-22

First Post: 2023-02-16

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Sponsor: AstraZeneca

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module